Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Markets are digesting a clear rates move catalyst titled "Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know". Bristol Myers Squibb has raised its dividend for 17 straight years, but a looming patent cliff and $43 billion in debt put the pace of future increases on a collision course with the drugs Wall Street is betting everything on.

Moves in duration reprice equity multiples and credit conditions across the whole board, not just one sector. Rate-sensitive growth stocks, REITs, and long-duration tech usually feel the move first when the long end jumps or collapses. Yields are the transmission with the 10Y near 5.19%: the equity implication only sticks if the long end stays in motion after the headline. Follow-through in the 10Y over the next session.